Best Life Sciences Stocks To Invest In 2014

With shares of Corning (NYSE:GLW) trading around $15, is GLW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Corning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates through five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences.�Corning launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices, such as smart phones, tablets, and notebook computers. Smart phones, tablets, and notebook computers and their related materials are seeing explosive growth in developed and developing countries around the world. Companies that provide the products necessary to develop and improve existing technology, like Corning, will see a continued rise in profits as consumers and companies demand products that maximize their efforts.

10 Best Supermarket Stocks To Buy For 2015: Avanir Pharmaceuticals Inc(AVNR)

Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. The company primarily offers NUEDEXTA, a unique proprietary combination of dextromethorphan and low-dose quinidine for the treatment of pseudobulbar affect. Its product line also comprises AVP-923 in Phase II clinical trial for the treatment of central neuropathic pain in patients with multiple sclerosis; and in Phase III trial for the treatment of patients with diabetic peripheral neuropathic pain. In addition, the company provides Docosanol 10% cream, an over-the-counter product for cold sores treatment. Avanir Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California.

Advisors' Opinion:

• [By Keith Speights]

  On a roll
  Avanir Pharmaceuticals (NASDAQ: AVNR  ) is on a roll. After solid gains during the first week of June, the stock jumped another 19% this week.

• [By Roberto Pedone]

  Avanir Pharmaceuticals (AVNR) is a pharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders. This stock closed up 1.3% to $4.52 in Tuesday's trading session.

  Tuesday's Range: $4.38-$4.59
  
  52-Week Range: $2.34-$6.00
  
  Tuesday's Volume: 1.41 million
  
  Three-Month Average Volume: 2.76 million

  From a technical perspective, AVNR bounced modestly higher here right off its 50-day moving average of $4.42 with lighter-than-average volume. This move is starting to push shares of AVNR within range of triggering a big breakout trade. That trade will hit if AVNR manages to take out some near-term overhead resistance levels at $4.71 to $5.07 with high volume.

  Traders should now look for long-biased trades in AVNR as long as it's trending above some near-term support at $4.20 and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.76 million shares. If that breakout hits soon, then AVNR will set up to re-test or possibly take out its 52-week high at $6.

Best Life Sciences Stocks To Invest In 2014: Renishaw PLC (RSW)

Renishaw plc is a metrology company. The Company is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products. The Company operates in two segments: metrology and healthcare products. The Company�� metrology segment product include Machine Tool Probe Systems, Co-ordinate Measuring Machine (CMM) products, large scale metrology, fixtures, materials research, styli for probe systems, performance testing products, gauging and position encoders. Its healthcare products include Dental Scanners, Raman Microscopes, Dental CAD Software, Neurosurgical robot, Structural and Chemical Analyser, In situ monitors and Neurosurgical Implantables. Advisors' Opinion:

• [By Inyoung Hwang]

  Renishaw Plc (RSW) tumbled 5.7 percent to 1,580 pence, its lowest price since Aug. 7. The maker of precision tools said revenue for the quarter ended in September fell to 79 million pounds from 95.9 million pounds in the year-ago period.

Best Life Sciences Stocks To Invest In 2014: Movado Group Inc. (MOV)

Movado Group, Inc. designs, sources, markets, and distributes fine watches. It operates in two segments, Wholesale and Retail. The company offers its watches under the Coach, Concord, Ebel, ESQ, Scuderia Ferrari, HUGO BOSS, Juicy Couture, Lacoste, Movado, and Tommy Hilfiger brands to jewelry store chains, department stores, independent regional jewelers, licensed partner retail stores, and a network of independent distributors. It is also involved in the after-sales service activities and shipping. In addition, Movado Group, Inc. operates retail outlet stores. As of January 31, 2013, the company operated 34 outlet stores. It operates principally in the United States, the Middle East, Europe, Asia, and the Americas. The company was formerly known as North American Watch Corporation and changed its name to Movado Group, Inc. in 1996. Movado Group, Inc. was founded in 1961 and is headquartered in Paramus, New Jersey.

Advisors' Opinion:

• [By Andrew Marder]

  Wholesale growth
  On the wholesale side of the business, Fossil is really playing to its strengths. Last quarter, wholesale revenue rose 13.5%, with the European division seeing the strongest growth. That business competes most directly with the Movado Group (NYSE: MOV  ) , which produces watches for most of the designers that Fossil doesn't cover. To compare, Movado's revenue was up just 6.1% last quarter. Fossil's edge came from the company's strong portfolio of brands -- which is what we're going to call a segue.

• [By Lisa Levin]

  Movado Group (NYSE: MOV) shares reached a new 52-week low of $33.49. Movado's trailing-twelve-month profit margin is 8.48%.

  MDC Holdings (NYSE: MDC) shares fell 1.16% to touch a new 52-week low of $25.60. MDC Holdings' PEG ratio is 3.14.

• [By Jake L'Ecuyer]

  Movado Group (NYSE: MOV) was also up, gaining 9.18 percent to $45.89 after the company reported upbeat Q4 earnings and issued a strong FY15 outlook.

Best Life Sciences Stocks To Invest In 2014: Brookline Bancorp Inc.(BRKL)

Brookline Bancorp, Inc. operates as the holding company for Brookline Bank, Bank Rhode Island, and The First National Bank of Ipswich, which provide commercial and retail banking services, and cash management and investment services to customers in Central New England. The company accepts various deposit products, including non-interest-bearing checking accounts, interest-bearing NOW accounts, savings accounts and money market savings accounts, certificate of deposit accounts, individual retirement accounts, and other qualified plan accounts. Its loan portfolio comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; auto loans; loans to business entities consisting of commercial lines of credit; and loans to condominium associations, as well as loans for financing equipment used by small businesses. Brookline Bancorp, Inc. also provides financing for construction and development projects, home equity, and other consumer l oans; and loans to finance coin-operated laundry, dry cleaning, and convenience store equipment and businesses. As of January 25, 2012, it operated 43 branches in Massachusetts and Rhode Island. The company was founded in 1871 and is headquartered in Brookline, Massachusetts.

Advisors' Opinion:

• [By Dividends4Life]

  Memberships and Peers: PBCT is a member of the S&P 500 and a member of the Broad Dividend Achievers��Index. The company's peer group includes: Bank of America Corporation (BAC) with a 0.3% yield, Brookline Bancorp, Inc. (BRKL) with a 3.7% yield and Westfield Financial Inc. (WFD) with a 3.5% yield.

• [By CRWE]

  Brookline Bancorp, Inc. (NASDAQ:BRKL) announced today that it will report third quarter earnings 2012 at the close of business Wednesday, October 24, 2012. Management will host a conference call to review this information at 1:30 PM Eastern Time on Thursday, October 25, 2012.

Best Life Sciences Stocks To Invest In 2014: DexCom Inc.(DXCM)

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. The company also provides the SEVEN PLUS, which incorporates additional user interface and algorithm enhancements that are intended to make its glucose monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark approvals. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for conti nuously monitoring blood glucose levels in patients hospitalized for various conditions. It also has development agreement with Insulet Corporation to integrate its continuous glucose monitoring technology into Insulet?s wireless, handheld OmniPod System Personal Diabetes Manager; and a joint development agreement with Animas Corporation to integrate its continuous glucose monitoring technology into Animas insulin pumps. The company was founded in 1999 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Sean Williams]

  Where's the beef, DexCom?
  Sometimes a company's products make a lot of sense on paper, but the practical application doesn't go nearly as smoothly. This is how I'd describe medical monitoring device maker DexCom (NASDAQ: DXCM  ) , which has an array of glucose monitoring devices to help diabetes patients better manage their disease. Make no mistake about it; the number of diabetes diagnoses in this country is rising in accord with our obesity rate. Therefore, a company like DexCom, which makes the DexCom G4 System monitor, could be a big hit, and certainly has a wide enough audience to cater to.

Best Life Sciences Stocks To Invest In 2014: Legal & General Group PLC (LGEN)

Legal & General Group Plc is a provider of risk, savings and investment management products in the United Kingdom. The Company's operating segments include Protection and Annuities segment consisting of individual and group protection, individual and bulk purchase annuities, longevity and general insurance; Savings segment consisting of non-profit investment bonds, non-profit pensions (including self-invested personal pensions (SIPPs)), individual savings account (ISAs), retail unit trusts and retail platform businesses; Investment management segment consisting of institutional fund management and LGIM America (LGIMA); US Protection segment consisting of individual protection and universal life contracts, and Group capital and financing consists of shareholders��equity supporting the non profit Protection and Annuities and Savings businesses. In August 2013, Legal & General Group Plc announced the acquisition of Lucida Limited. Advisors' Opinion:

• [By Rupert Hargreaves]

  Unfortunately, Prudential only offers a dividend yield of 2.4% at present, below that of its peers, such as Aviva (AV) and Legal & General (LGEN). Moreover, city analysts only expect Prudential to increase its payout by 10% this year and 5% during 2014.

Best Life Sciences Stocks To Invest In 2014: Halcon Resources Corp (HK)

Halcon Resources Corporation (Halcon Resources), incorporated on February 5, 2004, is an independent energy company focused on the acquisition, production, exploration and development of onshore liquids-rich oil and natural gas assets in the United States. The Company has oil and natural gas reserves located primarily in Texas, North Dakota, Louisiana, Oklahoma and Montana. On August 1, 2012, the Company acquired GeoResources by merger. On December 6, 2012, the Company completed the acquisition of entities owning approximately 81,000 net acres prospective for the Bakken / Three Forks formations primarily located in Williams, Mountrail, McKenzie and Dunn Counties, North Dakota (the Williston Basin Assets), from Petro-Hunt, L.L.C. and Pillar Energy, LLC (the Petro-Hunt parties). As of December 31, 2012, the Company has working interests in approximately 128,000 net acres prospective for the Bakken / Three Forks formations in North Dakota and Montana.

The Company�� Woodbine / Eagle Ford acreage is prospective for the Woodbine, Eagle Ford and other formations, with targeted depths ranging anywhere from 7,000 feet to 10,400 feet. As of December 31, 2012, The Company has approximately 198,000 net acres leased or under contract primarily in Leon, Madison, Grimes, Brazos, and Polk Counties, Texas. The Company is the operator and has a 100% working interest in more than 12,000 net acres in Wichita and Wilbarger Counties, Texas that it is actively water flooding in shallow Cisco aged Pennsylvania sandstone and limestone reservoirs. As of December 31, 2012, the Company produced 484 million barrels of oil equivalent from approximately 700 active producing wells and approximately 230 active water injection wells.

The Company�� position in the La Copita Field covers 3,720 gross acres and 2,829 net acres in Starr County, Texas. As of December 31, 2012, the Company�� average net daily production was 623 barrels of oil equivalent per day. The Company operates 100% of this production a! nd its working interest ranges from 75% to 100%. The Company has various other oil and natural gas properties with varying working interests located across the United States, including the Austin Chalk Trend and Eagle Ford Shale in Texas, the Fitts-Allen Fields in Central Oklahoma, and various other areas across South Louisiana, Montana, North Dakota, New Mexico, and West Virginia.

Advisors' Opinion:

• [By David Sterman]

   

  2. Halcon Resources (NYSE: HK) Insiders bought more than $2 million of this energy exploration firm in early August as part of a secondary share offering priced at $5.10 a share. In the past 10 days, as shares have slipped below the $5 mark, insiders have continued to accumulate shares.

  Halcon has a legion of fans in the financial blogosphere, and this recent post typifies the bullish sentiment of some.

• [By Aimee Duffy]

  A look ahead
  Despite these record numbers, by most accounts the Eagle Ford is just getting started. Tens of billions of dollars are being invested in the play this year, which means there will likely be many bright days ahead for South Texas. In fact, parts of the play have barely been tapped into. Consider the work that Halcon Resources (NYSE: HK  ) is doing in the East Texas portion of the play. The company announced earlier this month that production results from the last two wells it drilled are 18% higher than any well it has drilled in the area so far. On top of that, the output is 94% crude oil.